Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab and Celecoxib in Metastatic Colorectal Cancer
NCT00466505Phase 2Completed
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Start
- May 2005
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib oral solution in colorectal cancer (CRC), sponsored by Vanderbilt-Ingram Cancer Center. Started May 2005; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00466505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00466505.